The Ledger, every show

“There's probably going to be more opportunities like up council and our other businesses. That's the VC fallen angels, the businesses that have raised a lot of capital, but maybe haven't grown into, haven't fully grown into the scale that they should be at. So…”

“Not quite, but we'll definitely do a few million in revenue this year.”

“So it was a marketplace model, and our customers were like Pfizer and Novartis and Inovoderm, and they would pay us 10 to 20,000 dollars per patient to recruit a patient. We would split that with the doctor.”

“They had raised, you know, somewhere around 20, twenty-five million dollars from some really great VCs, but I think they didn't achieve the kind of escape velocity That maybe it would require to go on and continue raising capital after that.”

“So the sellers are making around 70% of everything that they're selling. We do a revenue share with the note takers and we also offer some Concentives upfront for them to participate just to get over the hurdle of, you know, taking that first step and doing a …”

“We have over 5000 monthly subscribers that participate in our marketplace.”

“We have almost a thousand elite note takers nationwide that are making money on our platform.”

“We're seeing churn anywhere between eight to 12% in a monthly period.”

“It costs us, you know, let's say a hundred to a 150 dollars to acquire a seller that's going to be then generating some revenue for us.”

“Year one revenue was pretty embarrassing. I think it was maybe 40,000 dollars, 45,000 dollars.”